Elite Pharmaceuticals, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 12/18/2017
Contact Info
  • 165 Ludlow Avenue
  • Northvale, NJ 07647

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001053369
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 1990
Employees 48 a/o Feb 01, 2017
Company Officers/Contacts
Nasrat Hakim CEO, President, Other
Carter J. Ward CFO, Secretary, Treasurer
Company Directors
Nasrat Hakim Chairman
David S. Caskey
Barry Dash
Eugene M. Pfeifer
Jeffrey Whitnell
Service Providers
Accounting/Auditing Firm
Buchbinder Tunick & Company LLP
155 US Highway 46
Wayne, NJ, 07470
United States
Securities Counsel
Richard Feiner, Esq.
381 Park Avenue South
New York, NY, 10016
United States
Investor Relations Firm

Not Available
ELTP Security Details
Share Structure
Market Value1 $100,966,634 a/o Jan 12, 2018
Authorized Shares 995,000,000 a/o Nov 04, 2016
Outstanding Shares 788,801,827 a/o Nov 02, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 766,363,798 a/o Jun 15, 2017
Par Value 0.01
Shareholders of Record 130 a/o Jun 14, 2017
Short Selling Data
Short Interest 26,493 (-32.98%)
Dec 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security